Rajagopalan Harith purchased $18K of GUTS
Rajagopalan Harith (Chief Executive Officer) purchased 25,000 shares of FRACTYL HEALTH, INC. (GUTS) at $0.73 on 2026-06-10.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the CEO’s open-market purchase of 25,000 shares at $0.7301/share, which may slightly improve sentiment but lacks fundamental follow-through in the text.
Market read
Traders may treat this as a small sentiment input, but it is unlikely to drive a major repricing without additional company catalysts.
What to watch
The article provides only the transaction details; it does not include prior insider activity frequency, option exercises, or any concurrent operational/company catalysts.
Background
The filing is an SEC Form 4 insider transaction for FRACTYL HEALTH, INC. (GUTS).
Ticker impact
CEO Rajagopalan Harith bought 25,000 shares of FRACTYL HEALTH (GUTS) in an open-market Form 4 on 2026-06-10.
Likely limited/short-lived impact; more relevant for monitoring insider confidence than for a standalone trade.
The disclosure is a Form 4 insider purchase with no accompanying company-specific news (no guidance, deal, or regulatory action).
Market effects
No sector read-across; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Insider buys under a non-10b5-1 plan can still be routine liquidity/portfolio actions and may not signal near-term upside.
Key entities
- issuerFRACTYL HEALTH, INC.
Company whose shares were purchased by its CEO via an open-market transaction.
- insiderRajagopalan Harith
CEO and director who reported the purchase on Form 4.
